FDA Inspection 711843 — Aurobindo Pharma Limited
The FDA completed an inspection of Aurobindo Pharma Limited on December 22, 2010 in Sangareddy. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- December 22, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sangareddy (India)